Sirtuin 1 (SIRT1): A potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation

Human Pathology

Volumn 44, Issue 6, 2013, Pages 1125-1130

  Dickson, Brendan C ^a   Riddle, Nicole D ^b   Brooks, John S ^c   Pasha, Theresa L ^d   Zhang, Paul J ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Myoid differentiation; SIRT1; Soft tissue neoplasms

Indexed keywords

SIRTUIN 1;

ALVEOLAR SOFT PART SARCOMA; ANGIOMYOLIPOMA; ARTICLE; CLEAR CELL SARCOMA; CYTOPLASM; DESMOID TUMOR; DESMOPLASTIC SMALL ROUND CELL TUMOR; EWING SARCOMA; FASCIITIS; FIBROMATOSIS; GASTROINTESTINAL STROMAL TUMOR; GLOMUS TUMOR; HEART MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEIOMYOMA; LEIOMYOSARCOMA; LIPOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NEPHROBLASTOMA; NEURILEMOMA; OSTEOSARCOMA; PROSTATE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHABDOMYOSARCOMA; SARCOMA; SKELETAL MUSCLE; SMOOTH MUSCLE; SOFT TISSUE CANCER; SOLITARY FIBROUS TUMOR; STROMA; SYNOVIAL SARCOMA; UNDIFFERENTIATED PLEOMORPHIC SARCOMA;

CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; SIRTUIN 1; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878116031     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.10.001     Document Type: Article

References (26)

1. N. Dali-Youcef, M. Lagouge, S. Froelich, C. Koehl, K. Schoonjans, and J. Auwerx Sirtuins: the "magnificent seven", function, metabolism and longevity Ann Med 39 2007 335 345
2. S. Imai, F.B. Johnson, R.A. Marciniak, M. McVey, P.U. Park, and L. Guarente Sir2: an NAD-dependent histone deacetylase that connects chromatin silencing, metabolism, and aging Cold Spring Harb Symp Quant Biol 65 2000 297 302
3. H.L. Cheng, R. Mostoslavsky, and S. Saito Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice Proc Natl Acad Sci U S A 100 2003 10794 10799
4. S. Hisahara, S. Chiba, and H. Matsumoto Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation Proc Natl Acad Sci U S A 105 2008 15599 15604
5. C.M. Backesjo, Y. Li, and U. Lindgren Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells Cells Tissues Organs 189 2009 93 97
6. G. Blander, A. Bhimavarapu, and T. Mammone SIRT1 promotes differentiation of normal human keratinocytes J Invest Dermatol 129 2009 41 49
7. M. Fulco, Y. Cen, and P. Zhao Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt Dev Cell 14 2008 661 673
8. A.V. Peeters, S. Beckers, and A. Verrijken Association of SIRT1 gene variation with visceral obesity Hum Genet 124 2008 431 436
9. J. Sequeira, G. Boily, and S. Bazinet Sirt1-null mice develop an autoimmune-like condition Exp Cell Res 314 2008 3069 3074
10. R. Firestein, G. Blander, and S. Michan The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth PLoS One 3 2008 e2020
11. K. Abdelmohsen, R. Pullmann Jr., and A. Lal Phosphorylation of HuR by Chk2 regulates SIRT1 expression Mol Cell 25 2007 543 557
12. K. Kojima, R. Ohhashi, and Y. Fujita A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells Biochem Biophys Res Commun 373 2008 423 428
13. D.M. Huffman, W.E. Grizzle, and M.M. Bamman SIRT1 is significantly elevated in mouse and human prostate cancer Cancer Res 67 2007 6612 6618
14. J. Ford, M. Jiang, and J. Milner Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival Cancer Res 65 2005 10457 10463
15. H. Ota, E. Tokunaga, and K. Chang Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells Oncogene 25 2006 176 185
16. W. Stunkel, B.K. Peh, and Y.C. Tan Function of the SIRT1 protein deacetylase in cancer Biotechnol J 2 2007 1360 1368
17. B. Peck, C.Y. Chen, and K.K. Ho SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2 Mol Cancer Ther 9 2010 844 855
18. H. Ota, E. Tolunaga, and K. Chang Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells Oncogene 25 2006 176 185
19. N. Kabra, L. Zhenyu, and L. Chen SirT1 is an inhibitor of proliferation and tumor formation in colon cancer J Biol Chem 284 2009 18210 18217
20. D.C. Allred, J.M. Harvey, M. Berardo, and G.M. Clark Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 1998 155 168
21. M. Tanno, J. Sakamoto, T. Miura, K. Shimamoto, and Y. Horio Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1 J Biol Chem 282 2007 6823 6832
22. Q. Jin, T. Yan, X. Ge, C. Sun, X. Shi, and Q. Zhai Cytoplasm-localized SIRT1 enhances apoptosis J Cell Physiol 213 2007 88 97
23. M. Fulco, R.L. Schiltz, and S. Iezzi Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state Mol Cell 12 2003 51 62
24. A. Bedalov, and J.A. Simon Sir2 flexes its muscle Dev Cell 5 2003 188 189
25. W.E. Farnsworth Prostate stroma: physiology Prostate 38 1999 60 72
26. E. Lara, A. Mai, and V. Calvanese Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect Oncogene 28 2009 781 791